Avience Biomedicals Peer Comparison

NSE: AVIENCE

₹271.70

₹-10.15 (-3.60%)

As on 14-Oct-2026IST

Market cap

₹149 Cr

Revenue (TTM)

₹45 Cr

P/E Ratio

17

P/B Ratio

2.8

Div. Yield

0 %

Edit

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Market cap (₹ Cr)	149	16,079	1,427	742	331
Revenue (₹ Cr)	45	1,997	342	92	183
Net Profit (₹ Cr)	7.23	307.01	55.72	4.71	12.72
Net Margin (%)	15.73	14.56	16.04	5.06	6.90
RoE (%)	49.90	10.63	25.55	4.92	10.39
Price to Earnings	17.03	51.03	25.61	60.40	30.38
Price-To-Book	2.81	5.05	2.92	5.31	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Operating Revenue	45.24	1,669.83	313.14	92.43	--
Total Income	45.97	1,758.96	325.22	93.00	--
Total Expenditure	33.79	1,214.12	251.50	82.12	--
EBITDA	11.45	455.71	61.64	10.31	--
Depreciation	0.86	83.18	7.03	3.89	--
EBIT	10.59	372.53	54.61	6.42	--
Interest	1.52	14.32	14.97	0.41	--
Other Income	0.73	89.13	12.08	0.57	--
Exceptional Items	--	--	-16.97	--	--
Profit before Tax	9.80	452.52	34.74	6.59	--
Provision for Tax	2.57	113.96	19.06	1.88	--
Profit after Tax	7.23	338.56	15.68	4.71	--

Liabilities (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Shareholder's Funds	22.78	2,765.66	189.95	98.04	--
Minority Interest	--	--	--	--	--
Non-Current Liabilities	10.16	56.40	85.42	14.44	--
Current Liabilities	23.51	457.71	179.14	18.62	--
Total Liabilities	56.45	3,279.77	455.50	131.33	--

Assets (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Non-Current Assets	19.28	1,269.89	189.88	76.67	--
Current Assets	37.17	2,009.87	264.64	54.44	--
Total Assets	56.45	3,279.77	455.50	131.33	--
Total Debt*	22.16	177.65	166.29	17.82	--
Net Current Assets	13.66	1,552.17	85.50	35.81	--
Contingent Liabilities	0.40	77.12	19.30	5.29	--

Cashflow (₹ Cr)

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Cash From Operating Activities	3.61	233.05	17.21	3.02	--
Cash Flow from Investing Activities	-8.81	-1,187.18	-77.47	-14.74	--
Cash from Financing Activities	9.25	950.51	53.18	-0.60	--
Net Cash Inflow / Outflow	4.05	-3.63	-7.08	-12.32	--

Ratios

Profitability Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
ROCE (%)	34.16	20.37	16.17	6.16	--
ROE (%)	49.90	16.01	8.92	4.92	--
ROA (%)	15.90	12.99	3.95	3.60	--
EBIT Margin (%)	26.92	32.63	23.54	11.77	--
Net Margin (%)	15.73	19.25	4.82	5.06	--
Cash Profit Margin (%)	17.89	25.15	7.25	7.98	--

Growth Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Revenue Growth (%)	88.77	21.37	53.77	-24.14	--
EBIT Growth (%)	169.91	30.11	80.39	-46.94	--
Net Profit Growth (%)	237.76	31.09	-27.54	-58.34	--
EPS Growth (%)	175.19	24.16	-44.23	-58.34	--
Book Value Growth (%)	266.73	88.41	17.39	5.05	--

Valuation Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Price / Earnings	0.00	67.10	0.00	48.10	--
Price / Book Value	0.00	8.22	0.00	2.31	--
Dividend Yield (%)	--	0.16	--	0.00	--
EV/EBITDA	1.75	41.75	1.64	22.15	--
Market Cap (₹ Cr)	0.00	22,718.23	0.00	226.53	--

Solvency Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Debt to Equity	0.97	0.06	0.88	0.18	--
Short term debt to equity ratio	0.50	0.06	0.29	0.00	--
Current Ratio	1.58	4.39	1.48	2.92	--
Quick Ratio	1.03	3.77	0.97	1.83	--
Interest Coverage	7.45	32.59	3.32	17.26	--

Operating Efficiency Ratios

	Avience Biomedicals	Poly Medicure	Q-Line Biotech	Saakshi Medtech	QMS Medical
Debtors to sales (%)	38.05	20.94	26.38	23.68	--
Asset Turnover	0.99	0.64	0.79	0.82	--
Receivable days	102.08	67.43	63.55	66.41	--
Inventory Days	102.74	55.13	113.91	71.27	--
Payable days	86.43	74.14	143.30	54.28	--
Cash Conversion Cycle	118.39	48.42	34.16	83.40	--